3027 Townsgate Road
Suite 300
Westlake Village, CA 91361
United States
805 418 5006
https://www.arcutis.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 296
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Todd Franklin Watanabe M.A. | President, CEO & Director | 1,01M | N/A | 1968 |
Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Independent Director | 60,83k | N/A | 1955 |
Mr. Rajvir Madan | Chief Digital & Technology Officer | N/A | N/A | N/A |
Ms. Latha Vairavan | Vice President of Finance & Investor Relations | N/A | N/A | N/A |
Ms. Courtney Barton | VP and Chief Compliance Officer & Privacy Officer | N/A | N/A | 1983 |
Ms. Bethany Dudek | Chief Technical Officer | N/A | N/A | N/A |
Ms. Jessica Robison | VP of Finance & Corporate Controller | N/A | N/A | N/A |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Arcutis Biotherapeutics, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 5. Die grundlegenden Scores sind Audit: 6, Vorstand: 5, Shareholderrechte: 3, Kompensation: 8.